N. Anand

发表

Discovery of a novel class of highly potent, selective, ATP-competitive, and orally bioavailable inhibitors of the mammalian target of rapamycin (mTOR).

K. Yamaguchi, J. Nuss, J. Woolfrey, 2013, Journal of medicinal chemistry.

Palladium(0)-catalysed arylations using pyrrole and indole-2-boronic acids

T. Gallagher, Christopher N. Johnson, G. Stemp, 1998 .

A simple, mild, catalytic, enantioselective addition of terminal acetylenes to aldehydes.

E. Carreira, N. Anand, 2001, Journal of the American Chemical Society.

Asymmetric synthesis of gamma-hydroxy alpha,beta-unsaturated aldehydes via enantioselective direct addition of propargyl acetate to aldehydes.

E. Carreira, N. Anand, E. El-Sayed, 2001, Organic letters.

A simple, mild, catalytic, enantioselective addition of terminal acetylenes to aldehydes.

E. Carreira, N. Anand, 2001, Journal of the American Chemical Society.

Pyrazolopyrimidines as dual Akt/p70S6K inhibitors.

Wei Xu, D. J. Matthews, J. Nuss, 2012, Bioorganic & medicinal chemistry letters.

Chapter 17 Emerging Therapies Based on Inhibitors of Phosphatidyl-Inositol-3-Kinases

J. Nuss, A. Tsuhako, N. Anand, 2009 .

Novel Carboxamide-Based Allosteric MEK Inhibitors: Discovery and Optimization Efforts toward XL518 (GDC-0973).

J. Martini, J. Nuss, Joerg Bussenius, 2012, ACS medicinal chemistry letters.

Design and evaluation of a series of pyrazolopyrimidines as p70S6K inhibitors.

Wei Xu, D. J. Matthews, J. Nuss, 2012, Bioorganic & medicinal chemistry letters.

Discovery of XL888: a novel tropane-derived small molecule inhibitor of HSP90.

S. Malek, J. Martini, J. Nuss, 2012, Bioorganic & medicinal chemistry letters.

NKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse Potential

W. Rubas, D. Gauvin, J. Zalevsky, 2017, The Journal of Pharmacology and Experimental Therapeutics.

RETRACTED: Biomimetic approach to Galbulimina type I alkaloids

J. Baldwin, K. Tchabanenko, R. Adlington, 2005 .

Abstract 3755: Comprehensive antitumor immune activation by a novel TLR7/8 targeting agent NKTR-262 combined with CD122-biased immunostimulatory cytokine NKTR-214

W. Rubas, C. Fanton, J. Zalevsky, 2018, Immunology.

Palladium(0)-Catalyzed Arylations Using Pyrrole and Indole 2-Boronic Acids.

T. Gallagher, Christopher N. Johnson, G. Stemp, 1998 .

NKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse Potential

W. Rubas, D. Gauvin, J. Zalevsky, 2017, The Journal of Pharmacology and Experimental Therapeutics.